Wednesday, March 08, 2023 12:09:31 AM
Wealth Management
AD Advisory Services Pty Ltd. (ADS) is an Australian-regulated wealth management company with 20 offices, 28 advisors, and $530+ million in funds under advice. ADS provides licensing solutions for financial advisers & accountants in Australia. ADS offers different licensing, compliance, and education solutions to financial planners to meet the specific needs of their practice.
That was for Three Months Ended March 31, 2022
Since then they acquired a 80% interest in a USA broker and a 50.1% interest in an international broker in Malta
CIM Securities, LLC
https://www.cimsecurities.com/
CIM Securities, LLC (herein referred to as "CIM Securities") is a broker-dealer registered with the United States Securities and Exchange Commission (SEC) and is a member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC). As a broker-dealer, CIM and our Investment Professionals offer brokerage services.
NSFX Ltd.
www.NSFX.com
NSFX Limited (the "Company") is a limited liability company registered under the Companies Act, Cap. 386 of the Laws of Malta with registration number C 56519. The Malta Financial Services Authority regulates NSFX with a License Number IS/56519. NSFX is authorized to deal on its account as a Category 3 licensed entity by the MFSA, receive and transmit orders on behalf of retail and professional clients, and hold and control clients' money and assets. NSFX trading platform services in the English, French, German, Italian, and Arabic markets, whereby customers can trade in currency, commodity, equity, and cryptocurrency-linked derivatives in real time.
Recent FDCT News
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/26/2024 10:12:50 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/03/2024 10:17:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 05:27:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:35:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 02:30:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:58:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 08:10:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/28/2023 05:32:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 07:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:45:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:30:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 07:00:46 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM